Navigating anxiety and depression in patients with nAMD

My guest for this episode is Professor Tariq Aslam, Professor of Ophthalmology and Interface Technologies at the University of Manchester and a Consultant Ophthalmologist specializing in the management of retinal disease. In this episode, we speak about how important it is to consider anxiety and depression when managing our patients with nAMD, and hear about the quick and effective measures that listeners can implement in their own clinic to identify patients at risk of anxiety and depression.Visit the resources page of the Barometer website to learn more about the rapid mental health screening tool that can be used to identify and support patients at risk of anxiety and depression https://www.amdbarometer.org/resources. For more information about patient-focused care, visit the nAMD Barometer and DR Barometer websites, and visit the Vision Academy website for information on managing clinically challenging situations and controversies in care.If you enjoyed this episode, SUBSCRIBE to “A Chat with Anat” to make sure you never miss an episode! Speaker disclosures: Professor Anat Loewenstein - Consultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurion, Pres-By, Roche, Sensor, WebMD, Xbrane. Professor Tariq Aslam - Consultancy: Bausch & Lomb, Bayer, Laboratoires, Novartis, Oraya, Théa Pharmaceuticals.Further information on other studies mentioned in this episode:Senra H, Balaskas K, Mahmoodi N, Aslam T. Experience of Anti-VEGF Treatment and Clinical Levels of Depression and Anxiety in Patients With Wet Age-Related Macular Degeneration. Am J Ophthalmol. 2017;177:213─224. Cimarolli VR, Casten RJ, Rovner BW, Heyl V, Sörensen S, Horowitz A. Anxiety and depression in patients with advanced macular degeneration: current perspectives. Clin Ophthalmol. 2015;10:55─63.Sivaprasad S, Oyetunde S. Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion. Clin Ophthalmol. 2016;10:939─46.Weinstein O, Cohen AD, Levy J, Zloto O, Freud T, Krieger I, Comaneshter D, Shemesh R. Anxiety in Patients with Neovascular Age-related Macular Degeneration. Ophthalmic Epidemiol. 2023;30:286─292. January 2025 | MA-PFM-OPHT-ALL-1086-1This podcast series is intended for HCPs, and is not intended for UK audiences. Always refer to local treatment guidelines and relevant prescribing information. Please review the product information before prescribing.This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise.The Barometer Program is managed by clinical leaders in ophthalmology as well as representatives from the IFA, IAPB and Bayer. The activities of the Barometer Program are funded and facilitated by Bayer where the scientists and representatives from IFA and IAPB retain decision authority to the research scope, methods, analysis of findings, and dissemination of the outputs of the Barometer Program.The Vision Academy is a group of over 80 international experts who, through their collective expertise, provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence. The Vision Academy is funded and facilitated by Bayer. The opinions and guidance of the Vision Academy outputs are those of its members and do not necessarily reflect the opinions of Bayer.